MycoBiomDB – Record Details (MyCo_6966)

Biomarker Record Details

Database ID: MyCo_6966
DB IDMyCo_6966
TitleAntibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans
Year2022
PMID34847408
Fungal Diseases involvedInvasive candidiasis
Associated Medical ConditionNone
GenusCandida
Speciesalbicans
OrganismCandida albicans
Ethical StatementThis study was conducted according to the principles expressed in the Declaration of Helsinki. The blood donation protocol and use of blood for this study were reviewed and approved by the institutional ethics committee of the University Hospital Jena (permission number 5070-02/17). The participants provided their written informed consent to participate in this study.
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceBlood
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameCEACAM6
Biomarker Full NameCEACAM6
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationGermany
CohortNone
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive candidiasis is the most common fungal disease among hospitalized patients in the developed world, and the fourth most common bloodstream infection in intensive care units. Invasive candidiasis is a major threat to immunosuppressed or critically ill patients and results in mortality rates as high as 40%, even when patients receive antifungal therapy; Candida albicans causes the majority of these infections.
TechniqueBioinformatics analysis
Analysis MethodTranscriptomics Approach
ELISA kitsNone
Assay DataNone
Validation Techniques usedTranscriptomics Approach
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone